Derrick Richardson

SVP, People & Culture at Alumis

Derrick Richardson is the Vice President of Program Management and brings over 25 years of experience spanning drug and medical device development. Derrick joins Alumis from Bristol Myers Squibb where he served as the Head of Cardiovascular Project Management overseeing the late-stage execution of a therapeutic area portfolio focused on thrombosis and cardiomyopathies including Mavacamten and Eliquis. Prior to the acquisition, Derrick served as Executive Director, Project Management at MyoKardia where he grew and developed a PMO that integrated rapidly evolving research, clinical development, BD and commercial functions.

He has also worked as a consultant to AbbVie and Genentech, providing Project Management, Business Operations and BD leadership across multiple therapeutic areas including oncology, multiple sclerosis and ocular disease. Earlier in his career, Derrick worked as a Mechanical Engineer at Stryker Corporation and Johnson & Johnson contributing to several innovations in laparoscopic surgery, lab automation and cardiovascular implants. He holds a BS in Product Design Engineering from Stanford University and a Master of Engineering in Mechanical Engineering from Cornell University.

Location

San Francisco, United States

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Alumis

Alumis is a precision medicines company looking to eliminate the “all comer” approach that is seen with today’s treatments for people with autoimmune disease. They are leveraging a precision analytics platform, powered by Foresite Labs, coupled with a team of experts with deep experience in precision medicine drug development and immunology, in order to create medicines that change the lives of people with autoimmune disease.


Employees

51-200

Links